Bionovo has a commitment to good governance and business practices. In furtherance of this commitment we regularly monitor developments in the area of corporate governance and review our processes and procedures in light of such developments. Bionovo complies with the rules and regulations promulgated by the Securities and Exchange Commission (SEC), and the NASDAQ Stock Market (NASDAQ), and we implement other corporate governance practices as we believe are in the best interest of the company and our stockholders.
Code of Business Conduct and Ethics
In 2005, Bionovo adopted a Code of Business Conduct and Ethics (the "Code of Conduct"), which is available below and also to any stockholder otherwise requesting a copy. All Bionovo employees, officers, and directors, including the Chief Executive Officer and Chief Financial Officer, are required to adhere to the Code of Conduct in discharging their work-related responsibilities. Employees are required to report any conduct that they believe in good faith to be an actual or apparent violation of the Code of Conduct. Amendments to the Code of Conduct, and any waivers from the Code of Conduct granted to directors or executive officers, will also be made available through the Company's website as they are adopted.
In keeping with the Sarbanes-Oxley Act of 2002, the Audit Committee of the Board of Directors has established procedures for the receipt and handling of complaints received by the Company regarding accounting, internal accounting controls or auditing matters.
Reports, concerns or complaints regarding accounting, internal accounting controls, or auditing matters, or questionable accounting or auditing matters may be made by calling Lighthouse Services at 1-800-398-1496. Such reports may be made confidentially and anonymously.
Committees of the Board of Directors
The Board maintains four standing committees – the Corporate Governance Committee, the Compensation Committee, the Audit Committee and the Nominating Committee. Committee membership is determined by the Board.. Each committee maintains a written charter detailing its authority and responsibilities. These charters are reviewed periodically as legislative and regulatory developments and business circumstances warrant and are available in their entirety below, as well as to any stockholder requesting a copy.
Stockholders wishing to communicate with the Board of Directors, or with a specific Board member, may do so by writing to the Board, or to the particular Board member, c/o Tom Chesterman, CFO, Bionovo, Inc., 5858 Horton Street, Suite 400, Emeryville, CA 94608. All mail addressed in this manner will be delivered to the Chair or Chairs of the Committees with responsibilities touching most closely on the matters addressed in the communication.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires the Company's directors and executive officers, and persons who own more than 10% of a registered class of the Company's equity securities (collectively "Reporting Persons"), to file with the SEC initial reports of ownership and reports of changes in ownership of Common Stock and other equity securities of the Company. Reporting Persons are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms they file.
To access Section 16(a) reports filed with the SEC, click on the link to the SEC's website.
Bionovo SEC Filings
Adobe Acrobat Reader is required to view the following files.
* View SEC Filings
* View Bionovo, Inc. Governance Guidelines
* View Code of Business Conduct and Ethics
* View Audit Committee Charter
* View Compensation Committee Charter
* View Nominating Committee Charter
* View Bionovo, Inc. By-Laws